DV-0100

N/A

Report date: 2024/03/28 17:42:32

Base Information

Drug NameDV-0100

Drug Alias NameiDCDendritic cell-based diabetes therapy - DiaVacsDV-0100DV-100DV-200

ClassificationVaccines > Development/production technology > Dendritic cell vaccineCell and gene therapy > Cell therapy > Immune system cell therapy > Dendritic cell therapy > Dendritic cell vaccineVaccines > Application > Prophylactic vaccine

Mechanisms of ActionImmunosuppressants

TargetsNot applicable

Therapy Area/IndicationsDiabetes Mellitus, Type 1

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusDiscontinued (Phase 2 Clinical)

Highest Status in ChinaN/A

Originator CompaniesDiavacs Inc

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesDiavacs Inc

Active IndicationsN/A

Inactive IndicationsDiabetes Mellitus, Type 1

Other Information

ATC CodeN/A